CARLSBAD, Calif.--(BUSINESS WIRE)--April 7, 2006--Invitrogen Corporation (Nasdaq:IVGN - News), a leading life sciences company with a broad portfolio of technologies to improve and accelerate biomedical research, drug discovery and commercial bioproduction, will be engaging partners, customers and industry peers in thought-provoking dialogue about major trends and opportunities at the Biotechnology Industry Organization’s BIO 2006 Chicago Annual International Conference taking place Sunday, April 9 through Wednesday, April 12 at McCormick Place.
